CDC Recommends Novavax COVID-19 Vaccine for Individuals Ages 12 through 17 Years
Posted on: August 23, 2022 - 10:10am
The CDC announced their recommendation of the Novavax COVID-19 vaccine for individuals aged 12 through 17 following the FDA's approval for emergency use. The Novavax vaccine is now approved under emergency use authorization (EUA) for individuals 12 and older.
To learn more about the Novavax COVID-19 vaccine please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/novavax.html